| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,065 | 5,805 | 7,858 | 949 | | Cost of Revenue | 563 | 499 | 359 | 267 | | | Gross Profit | 5,502 | 5,307 | 7,499 | 682 | | | Operating Expenses | | Research Development | 1,311 | 2,049 | 7,237 | 1,957 | | Selling General and Administrative | 9,915 | 12,357 | 10,057 | 6,824 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,724) | (9,099) | (9,796) | (8,099) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 254 | 490 | 635 | 858 | | Earnings Before Interest And Taxes | (5,469) | (8,609) | (9,161) | (7,241) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,469) | (8,609) | (9,161) | (7,241) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,469) | (8,609) | (9,161) | (7,241) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,469) | (8,609) | (9,161) | (7,241) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,469) | ($8,609) | ($9,161) | ($7,241) |
|
0.51% Nasdaq 
0.06 (0.99%) 
Income Statement
